The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder.
about
Magnesium for treating sickle cell diseasePhase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaMagnesium for treating sickle cell diseasePlasma interleukin-1beta concentration is associated with stroke in sickle cell disease.Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.Telomere length correlates with disease severity and inflammation in sickle cell disease.Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease.Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell diseaseRed blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants.Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatinPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell DiseaseTapered oral dexamethasone for the acute chest syndrome of sickle cell disease.A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Investigational agents for sickle cell disease.Sickle red cells induce adhesion of lymphocytes and monocytes to endotheliumEffect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndromeEffect of propranolol as antiadhesive therapy in sickle cell disease.Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell diseaseAn observational study of children with sickle cell disease in Kilifi, Kenya.The paradox of the neutrophil's role in tissue injury.Investigational selectin-targeted therapy of sickle cell disease.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Association of circulating transcriptomic profiles with mortality in sickle cell disease.A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.Splenic enlargement in adults with homozygous sickle cell disease: the Jamaican experience.Microfluidics for investigating vaso-occlusions in sickle cell disease.A prospective study of the association between sickle cell disease and hepatobiliary effects in BahrainPriapism in homozygous sickle cell patients: important clinical and laboratory associations.The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia.Haemoglobin oxygen saturation, leucocyte count and lactate dehydrogenase are predictors of elevated cerebral blood flow velocity in Nigerian children with sickle cell anaemia.Evaluation of clinical and laboratory correlates of sickle leg ulcers.Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1.Acute gastrointestinal vaso-occlusive ischemia in sickle cell disease: CT imaging features and clinical outcome.Adult Sickle Cell Anaemia Patients in Bone Pain Crisis have Elevated Pro-Inflammatory Cytokines.Platelet count as a predictor of the severity of sickle cell disease during pregnancyHematological parameters in Ghanaian sickle cell disease patients
P2860
Q24193246-49C009B2-41D3-41FE-A700-9DD1E6E7B281Q28540243-3633ECF8-EE64-43E4-ABF1-FD4116014292Q29994630-E2CD5B93-20FC-48BA-BEA9-33C9472DB610Q33598716-64F9DC0A-8DF1-4A35-A49A-27E13B22A65CQ33722654-C6154CDC-8CDC-4C0E-86F2-2BFC89F0E1A7Q33758996-A7F430D4-E6DC-4A41-A286-8F2F16AD5D8CQ33886410-690D6138-6247-4670-8A71-9FCCA0C35B77Q34013495-A3ECDBB0-9245-4366-AB73-5CC3BA9330D7Q34133852-2BFE5A23-7EED-4201-BDD5-B05CB3DB2558Q34255075-68C56510-85E6-49F9-AE6B-FD9729140FC7Q34478678-75A1331C-360D-4A76-976C-70D9264092AFQ34750520-C0B65C6B-61E0-40DA-A884-DB410DB7B33CQ35987429-6C505684-D1C2-4BE5-BDE5-4CFD25F8EF00Q36012888-D278166D-3058-43F7-BCA1-D12107CBA3D3Q36528046-72E2B54D-2331-4202-B209-7D713AF65986Q36543049-3FE6C13D-D30B-4FE0-9FD7-1CDD1317F3ABQ36941118-9A0C4E83-D6C5-4F6D-90D4-0283E70D20EFQ37045665-E04D1EAB-02BF-477D-B78D-99593A83D4D9Q37146392-B529EA3D-A7A7-449A-98DF-D9FC0E311EDEQ37275858-FBD9D8AB-ED49-49E7-9BFF-FBFD8F6F14FFQ37406275-EFFD8206-91A1-4053-AB90-996E4A700A88Q37413923-EF9B8A7A-EA80-4B8E-B34F-C8647E632A1AQ37811628-C77DA583-3F02-4524-BF32-C424A0AC8F3DQ38253064-1B435CBE-BDD2-46AD-BDE3-CB2845EAC2D6Q38804432-861193CE-6EFE-4FF6-A63A-3D0EB894D665Q38857629-2CDF705F-171C-4700-A542-ED212EFB8841Q38861043-0048BC81-FD93-47FD-86D1-5152E3F93B75Q38882070-C3E444C9-5F77-4A9E-B5F7-E38DAE8FC25FQ39219659-D5307483-E95F-4E10-A362-CE4B3256D877Q41347905-678F58A1-4C79-4FD3-90CB-A2ACB7C22581Q42759417-F7CDC83B-3643-429A-92C4-F21E5A3DEDEBQ45072571-DD21C664-869C-4474-B136-0A0E97C6729BQ48304119-1652F8CC-98AB-45EE-A26B-E919A0E21730Q50580233-F64B67D6-088E-42F9-B068-71186668B59CQ50652273-ABBF0F15-964E-43A7-A999-E0E1F644AF9BQ52877179-04A0A5A4-31E8-4E64-809D-ED7169383705Q55013382-C86C7B53-4C67-48C6-A8B3-F85C24A72082Q57624377-24106E88-5F41-4980-A90D-F559093EB039Q59135231-6E421263-9358-4224-A3D3-869902B3F1E8
P2860
The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The intriguing contribution of ...... disease - a red cell disorder.
@ast
The intriguing contribution of ...... disease - a red cell disorder.
@en
type
label
The intriguing contribution of ...... disease - a red cell disorder.
@ast
The intriguing contribution of ...... disease - a red cell disorder.
@en
prefLabel
The intriguing contribution of ...... disease - a red cell disorder.
@ast
The intriguing contribution of ...... disease - a red cell disorder.
@en
P1433
P1476
The intriguing contribution of ...... disease - a red cell disorder.
@en
P2093
Iheanyi Okpala
P356
10.1016/S0268-960X(03)00037-7
P577
2004-03-01T00:00:00Z